• MindImmune Therapeutics Closes $10.2M Series A Extension; Brings Round Total to $30M
  • MindImmune Therapeutics Secures $10.2M Series A Extension, Total Funding Reaches $30M
RightHill Ventures - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRightHill Ventures
RightHill Ventures logo

RightHill Ventures

0 followers

About RightHill Ventures

RightHill Ventures is a Providence‑based venture capital firm that partners with universities such as Brown and the University of Rhode Island to provide seed funding, mentorship and ecosystem support for early‑stage technology companies commercializing university research. The firm builds investment syndicates, connects accredited investors with founders, and helps innovators achieve product‑market fit and early growth milestones.

Recent News

MindImmune Therapeutics Closes $10.2M Series A Extension; Brings Round Total to $30M

Recent Deals

MindImmune Therapeutics Secures $10.2M Series A Extension, Total Funding Reaches $30M

November 25, 2025

Key Facts

HQ Location

Providence, United States

Founded

2022

Employees

1 - 10

Status

Investor

Investor Type

Venture Investor

Website

https://righthill.vc